SYNAREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synarel, and what generic alternatives are available?
Synarel is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYNAREL?
- What are the global sales for SYNAREL?
- What is Average Wholesale Price for SYNAREL?
Summary for SYNAREL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 3 |
Patent Applications: | 405 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SYNAREL |
What excipients (inactive ingredients) are in SYNAREL? | SYNAREL excipients list |
DailyMed Link: | SYNAREL at DailyMed |
![SYNAREL drug patent expirations Drug patent expirations by year for SYNAREL](/p/graph/s/t/SYNAREL-patent-expirations.png)
![Drug Prices for SYNAREL](/p/graph/drug-price/SYNAREL.png)
Recent Clinical Trials for SYNAREL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Diego | Early Phase 1 |
Shaare Zedek Medical Center | N/A |
New Hope Fertility Center | N/A |
Pharmacology for SYNAREL
Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
US Patents and Regulatory Information for SYNAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SYNAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SYNAREL
See the table below for patents covering SYNAREL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 71366 | ⤷ Sign Up | |
Israel | 60282 | NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LH RELEASING HORMONE,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
Japan | S6425794 | PRODUCTION OF NOVEL PEPTIDE DERIVATIVE OF LUTEINIZING HORMONE DISCHARGE HORMONE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SYNAREL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0021234 | 93C0049 | Belgium | ⤷ Sign Up | PRODUCT NAME: NAFARELIN. ACETAT; NAT. REG.: 194 IS 46 F 11 19920616; FIRST REG.: DK D.SP.NR. 8291 19900628 |
0021234 | SPC/GB93/056 | United Kingdom | ⤷ Sign Up | SPC/GB93/056, EXPIRES: 20050609 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |